Focus on Cancer

Focus on Cancer

By ReachMDMedicine
Download on the App Store

Focus on Cancer episodes

  • Latest Guidelines Bring Change for NSCLC Care
    Host: Matt Birnholz, MD
    Guest: Christine Bestvina, MD

    Highlighting the new guidelines brought forth by the National Comprehensive Cancer Network is Dr. Christine Bestvina, Assistant Professor of Medical Oncology from the University of Chicago. With this new and important information in mind, she explores how these modifications will impact the way we approach caring for our patients with non-small cell lung cancer.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • An Overwhelming Outcome After a NSCLC Patient's Change in Care
    Host: Matt Birnholz, MD
    Guest: Christine Bestvina, MD

    Dr. Christine Bestvina, Assistant Professor of Medical Oncology at the University of Chicago, retells the case of one non-small cell lung cancer patient whose need for a change in treatment course halfway through proved to be rewarding for both her and her patient.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • Tackling the Challenges of Care Coordination in NSCLC
    Host: Jennifer Caudle, DO
    Guest: Christine Bestvina, MD

    Family physician Dr. Jennifer Caudle and oncologist Dr. Christine Bestvina come together to take on the many questions surrounding care coordination in non-small cell lung cancer. Addressing a variety of topics like the various physicians involved and the challenges often encountered, Dr. Bestvina reveals the key strategies of seamless multidisciplinary teams to help you improve patient outcomes.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • Revealing the Key Statistics of NSCLC
    Guest: Everett E. Vokes, MD

    Dr. Everett Vokes, Professor at the University of Chicago, brings to light the reality of one of the deadliest diseases in the United States and the glaring repercussions encountered.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • Evolving Insights into the Pathophysiology of NSCLC
    Guest: Everett E. Vokes, MD

    Over the years, we’ve seen insights and advances emerge in the field of NSCLC, leading to better physician understanding and patient management. But at the heart of all breakthroughs and innovations lies the foundation of disease pathophysiology.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • Facing False Positives in CT-Based NSCLC Screenings
    Host: Matt Birnholz, MD
    Guest: Everett E. Vokes, MD

    To address some of the difficulties surrounding CT-based NSCLC screenings, Dr. Everett Vokes provides guidance to thwart false positives.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • Clinical Pearls for Challenging Cases of Advanced NSCLC
    Host: Matt Birnholz, MD
    Guest: Everett E. Vokes, MD

    With no one patient being the same, there’s a lot to consider when developing a treatment plan for advanced non-small cell lung cancer, and complex cases, such as elderly patients, can bring considerable uncertainty. Dr. Everett Vokes dives into the strategies he uses to guide his decisions when he’s faced with a challenging case.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • A Practical Perspective on Aggressive Disease Management in NSCLC
    Host: Matt Birnholz, MD
    Guest: Everett E. Vokes, MD

    Flipping the term “aggressive” on its head is Dr. Everett Vokes from the University of Chicago. Dr. Vokes unveils the term “intensive therapy” to describe his approach to aggressive NSCLC management and provides us with his rationale behind implementing this approach into practice.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • The Expanding Value of Biomarkers in NSCLC Treatment
    Host: Shira Johnson, MD
    Guest: Ross Camidge, MD, PhD

    The treatment landscape for non-small cell lung cancer is continuing to expand, and playing a major role in clinical decision-making are biomarkers. Dr. Ross Camidge reveals the importance of these molecular signatures with Dr. Shira Johnson and how he applies them in practice.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • NSCLC: An Aggressive Approach for Personalized Therapy
    Guest: Ross Camidge, MD, PhD

    Dr. Ross Camidge from the University of Colorado discusses the concepts to consider and his own personal rationales behind implementing aggressive disease management for patients with NSCLC.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min

About Focus on Cancer

From the publisher's feed

According to the American Cancer Society, yearly deaths from cancer are decreasing— marking the first period of decline in nearly 70 years. ReachMD takes a closer look at the driving forces behind…